MedTrace Logo

Lung Function in Post-COVID-19 Nursing Home Residents

NCT05866211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 184

Last updated 2024-12-24

No results posted yet for this study

Summary

The coronavirus disease 2019 (COVID-19) took a toll in institutionalised older adults, who represent a vulnerable population in European countries.

The aim of this study is to identify the predictive factors that worsens lung function in post-COVID nursing home (NH) residents.

This is a multicenter case-control study in nursing homes of Osona (Catalonia), where individuals with worsened (cases) and normal (controls) lung function will be studied. The inclusion criteria are: female and male from 65 to 95 years old, preserved cognitive capacity and positive diagnosis of COVID-19 at least 3 months prior.

We will assess sociodemographic variables, lung function \[spirometry\], fatigue \[Chalder Fatigue Scale\], frailty \[Clinical Frailty Scale\], and activities of daily living (ADL) \[modified Barthel index\].

Conditions

  • Post-COVID-19 Syndrome

Interventions

OTHER

Previous exposure to SARS-CoV-2

This is an observational study in which no intervention will be applied.

Sponsors & Collaborators

  • Catalan Board of Physiotherapists

    collaborator UNKNOWN

  • University of Vic - Central University of Catalonia

    lead OTHER

Eligibility

Min Age
65 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-25
Primary Completion
2022-11-30
Completion
2024-01-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05866211 on ClinicalTrials.gov